메뉴 건너뛰기




Volumn 189, Issue 8, 2014, Pages 975-982

Inhaled colistin in patients with bronchiectasis and chronic pseudomonas aeruginosa infection

Author keywords

Adherence; Nebulized antibiotics; Randomized controlled trial

Indexed keywords

ADMINISTRATION, INHALATION; ADULT; AGED; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CHRONIC DISEASE; COLISTIN; DOUBLE-BLIND METHOD; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUALITY OF LIFE; QUESTIONNAIRES; RUSSIA; TIME FACTORS; TREATMENT OUTCOME; UKRAINE;

EID: 84898994995     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201312-2208OC     Document Type: Article
Times cited : (220)

References (34)
  • 1
    • 77955283910 scopus 로고    scopus 로고
    • British thoracic society guideline for non- cf bronchiectasis
    • British Thoracic Society Bronchiectasis non-CF Guideline Group
    • Pasteur MC, Bilton D, Hill AT; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non- CF bronchiectasis. Thorax 2010;65:i1-i58.
    • (2010) Thorax , vol.65
    • Pasteur, M.C.1    Bilton, D.2    Hill, A.T.3
  • 2
    • 0022531170 scopus 로고
    • Inflammation: A two-edged sword- The model of bronchiectasis
    • Cole PJ. Inflammation: a two-edged sword- the model of bronchiectasis. Eur J Respir Dis Suppl 1986;147:6-15.
    • (1986) Eur J Respir Dis Suppl , vol.147 , pp. 6-15
    • Cole, P.J.1
  • 3
    • 84868207364 scopus 로고    scopus 로고
    • Immunity and bacterial colonisation in bronchiectasis
    • Whitters D, Stockley R. Immunity and bacterial colonisation in bronchiectasis. Thorax 2012;67:1006-1013.
    • (2012) Thorax , vol.67 , pp. 1006-1013
    • Whitters, D.1    Stockley, R.2
  • 4
    • 84867114791 scopus 로고    scopus 로고
    • Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis
    • Chalmers JD, Smith MP, McHugh BJ, Doherty C, Govan JR, Hill AT. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2012;186:657-665.
    • (2012) Am J Respir Crit Care Med , vol.186 , pp. 657-665
    • Chalmers, J.D.1    Smith, M.P.2    McHugh, B.J.3    Doherty, C.4    Govan, J.R.5    Hill, A.T.6
  • 11
    • 0030991452 scopus 로고    scopus 로고
    • Effects of airway infection by pseudomonas aeruginosa: A computed tomographic study
    • Miszkiel KA, Wells AU, Rubens MB, Cole PJ, Hansell DM. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study. Thorax 1997;52:260-264.
    • (1997) Thorax , vol.52 , pp. 260-264
    • Miszkiel, K.A.1    Wells, A.U.2    Rubens, M.B.3    Cole, P.J.4    Hansell, D.M.5
  • 14
    • 19044398177 scopus 로고    scopus 로고
    • A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis
    • Scheinberg P, Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005;127:1420-1426.
    • (2005) Chest , vol.127 , pp. 1420-1426
    • Scheinberg, P.1    Shore, E.2
  • 15
    • 11144228397 scopus 로고    scopus 로고
    • Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with pseudomonas aeruginosa
    • Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother 2005;39:39-44.
    • (2005) Ann Pharmacother , vol.39 , pp. 39-44
    • Drobnic, M.E.1    Suñé, P.2    Montoro, J.B.3    Ferrer, A.4    Orriols, R.5
  • 18
    • 84881556337 scopus 로고    scopus 로고
    • Orbit-2 investigators inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (orbit-2): A randomised, double-blind, placebocontrolled trial
    • Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, Cipolla D, Bruinenberg P, Gonda I; ORBIT-2 investigators. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebocontrolled trial. Thorax 2013;68:812-817.
    • (2013) Thorax , vol.68 , pp. 812-817
    • Serisier, D.J.1    Bilton, D.2    De Soyza, A.3    Thompson, P.J.4    Kolbe, J.5    Greville, H.W.6    Cipolla, D.7    Bruinenberg, P.8    Gonda, I.9
  • 19
    • 84898978178 scopus 로고    scopus 로고
    • Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (azli) for non-cystic fibrosis bronchiectasis (ncfb)
    • September, 2013, Barcelona, Spain. Abstract P4136
    • Barker AF. Two Phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB). Presented at the European Respiratory Society Annual Congress. September, 2013, Barcelona, Spain. Abstract P4136.
    • Presented at the European Respiratory Society Annual Congress
    • Barker, A.F.1
  • 20
    • 84866122783 scopus 로고    scopus 로고
    • British thoracic society national bronchiectasis audit 2010 and 2011
    • British Thoracic Society
    • Hill AT, Welham S, Reid K, Bucknall CE; British Thoracic Society. British Thoracic Society national bronchiectasis audit 2010 and 2011. Thorax 2012;67:928-930.
    • (2012) Thorax , vol.67 , pp. 928-930
    • Hill, A.T.1    Welham, S.2    Reid, K.3    Bucknall, C.E.4
  • 21
    • 77950606953 scopus 로고    scopus 로고
    • The adaptive aerosol delivery (aad) technology: Past, present, and future
    • Denyer J, Dyche T. The adaptive aerosol delivery (AAD) technology: past, present, and future. J AerosolMed PulmDrug Deliv 2010;23:S1-S10.
    • (2010) J AerosolMed PulmDrug Deliv , vol.23
    • Denyer, J.1    Dyche, T.2
  • 22
    • 84887341631 scopus 로고    scopus 로고
    • Multicenter randomized double blind placebo controlled trial of promixin (colistin) delivered through the i-neb in patients with non-cf bronchiectasis and chronic pseudomonas aeruginosa infection [abstract]
    • Haworth C, Foweraker J, Wilkinson P, Kenyon R, Bilton D. Multicenter randomized double blind placebo controlled trial of Promixin (colistin) delivered through the I-neb in patients with non-CF bronchiectasis and chronic Pseudomonas aeruginosa infection [abstract]. Am J Respir Crit Care Med 2013;187:A3511.
    • (2013) Am J Respir Crit Care Med , vol.187
    • Haworth, C.1    Foweraker, J.2    Wilkinson, P.3    Kenyon, R.4    Bilton, D.5
  • 23
    • 85027720729 scopus 로고    scopus 로고
    • Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonized with pseudomonas aeruginosa
    • September, 2013, Barcelona, Spain. Abstract 2732
    • Haworth C, Bilton D, Kenyon R. Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonized with Pseudomonas aeruginosa. Presented at the European Respiratory Society Annual Congress. September, 2013, Barcelona, Spain. Abstract 2732.
    • Presented at the European Respiratory Society Annual Congress
    • Haworth, C.1    Bilton, D.2    Kenyon, R.3
  • 24
    • 84898965355 scopus 로고    scopus 로고
    • Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis
    • September, 2013, Barcelona, Spain. Abstract 4650
    • Haworth C, Bilton D, Kenyon R. Adherence with inhaled colistimethate sodium during a 6 month study in patients with non-cystic fibrosis bronchiectasis. Presented at the European Respiratory Society Annual Congress. September, 2013, Barcelona, Spain. Abstract 4650.
    • Presented at the European Respiratory Society Annual Congress
    • Haworth, C.1    Bilton, D.2    Kenyon, R.3
  • 25
    • 0026871146 scopus 로고
    • A self-complete measure of health status for chronic airflow limitation. The st. George's respiratory questionnaire
    • Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145: 1321-1327.
    • (1992) Am Rev Respir Dis , vol.145 , pp. 1321-1327
    • Jones, P.W.1    Quirk, F.H.2    Baveystock, C.M.3    Littlejohns, P.4
  • 26
    • 62949217788 scopus 로고    scopus 로고
    • Comparison of methods to assess medication adherence and classify nonadherence
    • Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009;43:413-422.
    • (2009) Ann Pharmacother , vol.43 , pp. 413-422
    • Hansen, R.A.1    Kim, M.M.2    Song, L.3    Tu, W.4    Wu, J.5    Murray, M.D.6
  • 27
    • 84880078608 scopus 로고    scopus 로고
    • B301 investigators phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cf bronchiectasis
    • Bilton D, Daviskas E, Anderson SD, Kolbe J, King G, Stirling RG, Thompson BR, Milne D, Charlton B. B301 Investigators. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-CF bronchiectasis. Chest 2013;144:215-225.
    • (2013) Chest , vol.144 , pp. 215-225
    • Bilton, D.1    Daviskas, E.2    Anderson, S.D.3    Kolbe, J.4    King, G.5    Stirling, R.G.6    Thompson, B.R.7    Milne, D.8    Charlton, B.9
  • 28
    • 84865131777 scopus 로고    scopus 로고
    • Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (embrace): A randomised, double-blind, placebo-controlled trial
    • Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 380:660-667.
    • (2012) Lancet , vol.380 , pp. 660-667
    • Wong, C.1    Jayaram, L.2    Karalus, N.3    Eaton, T.4    Tong, C.5    Hockey, H.6    Milne, D.7    Fergusson, W.8    Tuffery, C.9    Sexton, P.10
  • 29
    • 84875524849 scopus 로고    scopus 로고
    • Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: The bat randomized controlled trial
    • Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EH, Koppers RJ, van der Werf TS, Boersma WG. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial. JAMA 2013;309:1251-1259.
    • (2013) JAMA , vol.309 , pp. 1251-1259
    • Altenburg, J.1    De Graaff, C.S.2    Stienstra, Y.3    Sloos, J.H.4    Van Haren, E.H.5    Koppers, R.J.6    Van Der Werf, T.S.7    Boersma, W.G.8
  • 30
    • 0036196105 scopus 로고    scopus 로고
    • Interpreting thresholds for a clinically significant change in health status in asthma and copd
    • Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002;19: 398-404.
    • (2002) Eur Respir J , vol.19 , pp. 398-404
    • Jones, P.W.1
  • 33
    • 84875543900 scopus 로고    scopus 로고
    • Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: The bless randomized controlled trial
    • Serisier DJ, Martin ML, McGuckin MA, Lourie R, Chen AC, Brain B, Biga S, Schlebusch S, Dash P, Bowler SD. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial. JAMA 2013;309:1260-1267.
    • (2013) JAMA , vol.309 , pp. 1260-1267
    • Serisier, D.J.1    Martin, M.L.2    McGuckin, M.A.3    Lourie, R.4    Chen, A.C.5    Brain, B.6    Biga, S.7    Schlebusch, S.8    Dash, P.9    Bowler, S.D.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.